Leaflet CRIXIVAN GOLD 400mg capsules

Indicated for: HIV-1 infection

Route of administration: oral

Substance: indinavir (protease inhibitor)

ATC: J05AE02 (Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors)

Precautions:
Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Indinavir is an antiretroviral medication used to treat human immunodeficiency virus (HIV) infection. It belongs to the class of protease inhibitors and works by blocking the HIV protease enzyme, which is essential for viral replication.

The medication is taken orally, usually three times a day, as directed by a doctor.

Side effects may include nausea, abdominal pain, diarrhea, dry mouth, or kidney stone formation. In rare cases, severe allergic reactions or changes in body fat distribution may occur.

Patients should strictly follow the treatment regimen and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.

General data about CRIXIVAN GOLD 400mg

  • Substance: indinavir
  • Date of latest medicines list: 01-07-2013
  • Product code: W13499001
  • Concentration: 400mg
  • Pharmaceutical form: capsules
  • Quantity: 180
  • Product type: Original
  • Prescription status: S - Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.

Concentrations available for indinavir

  • 100mg
  • 200mg
  • 333mg
  • 400mg